Company: CRNX
Filing Date: 2025-06-12
Form Type: 8-K
Source: 0000950170-25-085442
Chunk: 0

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-06-12
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

The annual meeting of stockholders of Crinetics Pharmaceuticals, Inc. (the “ Company”) was held online via live audio webcast on June 11, 2025 (the “ Annual Meeting”). At the Annual Meeting, there were present, virtually or by proxy, holders of 88,931,596 shares of common stock, or approximately 95% of the total outstanding shares eligible to be voted. The final voting results with respect to each proposal presented at the Annual Meeting are as follows:

Proposal One - Election of Directors

The Company’s stockholders approved the election of three Class I directors to the Board of Directors for three-year terms to expire at the 2028 annual meeting of stockholders. The results of such vote were:

                                      Votes For      Votes Withheld      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────
  R. Scott Struthers, Ph. D.         69,586,919          15,729,147             3,615,529  
  Matthew K. Fust                    67,615,092          17,700,974             3,615,529  
  Rogério Vivaldi Coelho, M. D.      68,864,528          16,451,538             3,615,529  

Proposal Two - Ratification of Selection of Independent Registered Accounting Firm

The Company’s stockholders ratified the selection of BDO USA, P. C. as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2025. The results of such vote were:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  88,742,805            129,064           59,727                     0  

Proposal Three - Approval, on an advisory basis, of the compensation of the Company’s named executive officers

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The results of such vote were:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  82,658,715          2,636,436           20,915             3,615,529  

SIGNATURES